Exelixis Announces May 8th Webcast of Presentation at the Deutsche Bank Securities 37th Annual Health Care Conference
May 02 2012 - 4:42PM
Business Wire
Exelixis, Inc. (NASDAQ: EXEL) announced today that Frank Karbe,
the company’s executive vice president and chief financial officer,
will present at the upcoming Deutsche Bank Securities 37th Annual
Health Care Conference at 4:50 p.m. EDT / 1:50 p.m. PDT on Tuesday,
May 8, 2012, in Boston. During the presentation, Mr. Karbe will
discuss the company’s development program and plans for
cabozantinib, and review the most recent publicly available data
for the compound. He will also provide a general business
update.
The presentation will be webcast and may be accessed via the
Event Calendar page under Investors at www.exelixis.com.
About Exelixis
Exelixis, Inc. is a biotechnology company committed to
developing small molecule therapies for the treatment of cancer.
Exelixis is focusing its proprietary resources and development
efforts exclusively on cabozantinib (XL184), its most advanced
product candidate, in order to maximize the therapeutic and
commercial potential of this compound. Exelixis believes
cabozantinib has the potential to be a high-quality,
broadly-active, differentiated pharmaceutical product that can make
a meaningful difference in the lives of patients. Exelixis has also
established a portfolio of other novel compounds that it believes
have the potential to address serious unmet medical needs, many of
which are being advanced by partners as part of collaborations. For
more information, please visit the company's web site at
http://www.exelixis.com.
Exelixis (NASDAQ:EXEL)
Historical Stock Chart
From Apr 2024 to May 2024
Exelixis (NASDAQ:EXEL)
Historical Stock Chart
From May 2023 to May 2024